Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,597 | -35,876 | -23,009 | -14,238 | -6,182 |
| Depreciation Amortization | 121 | 408 | 296 | 157 | 60 |
| Accounts payable and accrued liabilities | 489 | 30 | 492 | 176 | 46 |
| Other Working Capital | 623 | -868 | -610 | 170 | -207 |
| Other Operating Activity | 853 | 6,124 | 3,357 | 2,508 | 1,003 |
| Operating Cash Flow | $-9,511 | $-30,182 | $-19,474 | $-11,227 | $-5,280 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -11,631 | -17,084 | 9,747 | 3,724 | -1,375 |
| PPE Investments | -229 | -93 | -73 | -71 | -20 |
| Investing Cash Flow | $-11,860 | $-17,177 | $9,674 | $3,653 | $-1,395 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 741 | 71,606 | 279 | 279 | N/A |
| Financing Cash Flow | $741 | $71,606 | $279 | $279 | $N/A |
| Beginning Cash Position | 68,177 | 43,930 | 43,930 | 43,930 | 43,930 |
| End Cash Position | 47,547 | 68,177 | 34,409 | 36,635 | 37,255 |
| Net Cash Flow | $-20,630 | $24,247 | $-9,521 | $-7,295 | $-6,675 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,511 | -30,182 | -19,474 | -11,227 | -5,280 |
| Capital Expenditure | -229 | -93 | -73 | -71 | -20 |
| Free Cash Flow | -9,740 | -30,275 | -19,547 | -11,298 | -5,300 |